Windlas Biotech Ltd Quarterly Results

Gross Sales

202.71

195.02

187

175.15

171.29

Excise Duty

0

0

0

0

0

Net Sales

202.71

195.02

187

175.15

171.29

Other Operating Income

0

0

0

0

0

Other Income

4.94

4.11

4.84

4.13

4.44

Total Income

207.64

199.13

191.84

179.29

175.73

Total Expenditure

177.16

170.39

163.95

154.27

149.28

PBIDT

30.49

28.74

27.89

25.01

26.45

Interest

1.33

1.46

1.1

0.49

0.28

PBDT

29.16

27.28

26.79

24.52

26.17

Depreciation

8.34

6.94

6.5

6.21

3.54

Minority Interest Before NP

0

0

0

0

0

Tax

4.61

3.94

5.13

4.61

4.55

Deferred Tax

-0.06

0.82

-0.5

0.22

1.09

Reported Profit After Tax

16.28

15.58

15.66

13.48

16.99

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

16.28

15.58

15.66

13.48

16.99

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

16.28

15.58

15.66

13.48

16.99

EPS (Unit Curr.)

7.77

7.45

7.49

6.47

8.17

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.48

10.45

10.45

10.45

10.4

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

15.04

14.73

14.91

14.27

15.44

PBDTM(%)

14.38

13.98

14.32

13.99

15.27

PATM(%)

8.03

7.98

8.37

7.69

9.91